Dnovo

Developer of a hair loss treatment using reprogrammed stem cells

placeSan Francisco, California, United States calendar_todayFounded 2018 groups3 employees language dnovobio.com

Investor mix

17 investors on record.

Investor typeCountShare
Venture capital741%
Private equity16%
Other / undisclosed953%
Coming soon